Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in Insomnia

Pharmacy Times, July 2015 Digestive Health, Volume 81, Issue 7

This Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in Insomnia

Faculty

Jennifer A. Reinhold, PharmD, BCPS, BCPP

Associate Professor of Clinical Pharmacy

Department of Pharmacy Practice/

Pharmacy Administration

Philadelphia College of Pharmacy

University of the Sciences in Philadelphia

Philadelphia, Pennsylvania

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Outline the prevalence, pathophysiology, and consequences of insomnia.
  • Review patient-specific and drug specific factors in making therapeutic decisions.
  • Study the efficacy, safety, and differentiating characteristics of currently available treatment options for insomnia, particularly the newer-generation nonbenzodiazepines.
  • Discuss the pharmacist’s role in assisting physicians in individualizing treatment and educating patients about insomnia, as well as nonprescription and prescription treatments.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

July 6, 2015

Expiration date:

July 6, 2016

Estimated time to complete activity:

2.0 hours

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-067-H01-P. The activity is available for CE credit through July 6, 2016.